Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Camelid single-chain antibodies detect AD markers

July 25, 2014

Navidea forms radiopharmaceuticals enterprise with Rheumco

July 21, 2014

[123I]ABC-577 as a novel Abeta SPECT imaging agent

July 21, 2014

Researchers develop low-cost, rapid, point-of-care test for the detection of M. tuberculosis

July 18, 2014

C2N expands partnership with WUSM for Alzheimer's blood test

July 17, 2014

Ventana and Merck KGaA collaborate on companion diagnostic test

July 14, 2014

Novel radiotracer shows potential for PET imaging of LPA-1 receptor expression

July 4, 2014

Imaging neuroinflammation with a novel PET tracer

July 2, 2014

Vizamyl recommended for approval in E.U.

June 30, 2014

Molecular probe developed for optical imaging of Bcl-2 expression during chemotherapy

June 23, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.